Lights, Camera, Action!

Explore our curated photo gallery of standout moments from NextGen Omics & Spatial Biology US 2025. See if you can spot yourself!

BREAKING DOWN SILOS. CONNECTING EXPERTISE. ACCELERATING PATIENT IMPACT.

Precision Medicine East Logo
 

Precision Medicine East, formerly NextGen Omics, Spatial & Data US, brings together the scientific disciplines, technologies and decision-makers advancing drug development, clinical research, diagnostics and patient care. 

 


, ,


Introducing
Precision Medicine East

Precision medicine has changed, and so has our event in Boston.
Omics, spatial biology and AI have changed what’s possible in precision medicine. But turning that data into better decisions takes biomarker, pathology, data and clinical teams working together, and too often they still meet apart.

That’s why, from 2027, NextGen Omics, Spatial & Data US is now Precision Medicine East. In Boston, 15 years of omics and spatial community is joined by biomarkers, companion diagnostics and computational pathology, in four interconnected programs. The science you came for remains. What’s new is the East Coast’s precision medicine ecosystem, in one room. 

Watch our CEO and Founder, Cerlin Roberts, explain the thinking behind the change.

What is Precision Medicine East?

Precision Medicine East is a two-day conference in Boston for the people advancing precision medicine: R&D leaders, clinicians, researchers, data scientists, investors and technology providers. Organized by Oxford Global, it runs four interconnected programs in biomarkers and companion diagnostics, computational pathology, multi-omics, and AI and data, with spatial biology across the agenda. Small-group formats, pre-arranged meetings and dedicated zones for AI and startups turn the science into decisions.

Why attend Precision Medicine East

  • Explore the full precision medicine ecosystem: four interconnected programs in Biomarkers & CDx; Computational Pathology, AI & Precision Diagnostics; Multi-Omics Development & Applications; and AI, Data & Analysis, with spatial biology across the agenda.

  • Meet the people carrying precision medicine forward: R&D and clinical development leaders, clinicians, researchers, data scientists, investors and technology providers from pharma, biotech, academia and healthcare.

  • Work in formats built for exchange: Collaboration Hubs, panel discussions, closed-door sessions and roundtables, designed for discussion, not just presentation.
  • See what’s ready to use: live demonstrations in the AI & Data Zone, and the next wave of science in the Startup Zone.

  • Make the meetings that matter: pre-booked one-on-one meetings in the Networking Lounge, scheduled around the sessions so you never miss the content.
PM East Square Icon Image

About

NextGen Omics, Spatial & Data US is now Precision Medicine East.  Discover what’s changed.

Large Audience at Precision Medicine Event

Attend

 See who attends, how to bring your team and how to book your place. 

Partner Image

Partner

Showcase your offering to leading pharma and biotech decision makers

PM East Program

Program

Explore dynamic panels, engaging roundtables, and hands-on workshops

Onsite experiences at Precision Medicine East

Start-up Zone

A dedicated space for early-stage precision medicine companies to exhibit, pitch and meet investors and pharma partners, all in two days. Eligible start-ups receive a full conference pass, a 10-minute presentation slot and exhibition space to show their technology to the teams who would use it.

AI & Data Zone

A dedicated space where the companies building AI and data infrastructure for precision medicine meet the pharma, biotech and diagnostics teams who use it. See platforms in action through live demos, short technology talks and a closed-door roundtable on applying AI in precision medicine.

Partnering Program

 Shortlist the providers you want to meet, and we’ll arrange focused one-on-one meetings in the Networking Lounge during the breaks. You can also review requests from providers to accept the ones that fit your work.

Exhibition & Networking

Meet the technology and solution providers shaping precision medicine, with time built into both days to connect. Every break is a chance to continue a session’s conversation with peers from pharma, biotech, academia and healthcare. 

Featured Speakers for Precision Medicine East 2027

Abul Hassan Samee
Associate Professor, Integrative Physiology,
Baker IDI Heart & Diabetes Institute
Andrea Calabria
Senior Director, Computational Biology,
tesseratx.com
Asaf Rotem
Senior Director,
AstraZeneca
Chandra Saravanan
Director, Pathology,
Novartis Pharma
Clarence Yapp
Director of Microscopy & Computer Vision,
Harvard Medical School
Don Zack
prof,
Johns Hopkins University
Elaine Joseph
Director, Precision Medicine,
AstraZeneca
Elizabeth A. Sheppard
Vice Chair CAP HQIP Committee,
College of American Pathologists (CAP)
Frank Borriello
Founder & Chief Executive Officer,
Alloplex Biotherapeutics
Giorgio Gaglia
Senior Principal Scientist,
Sanofi
Greg Timp
Brosey Professor of Engineering,
Notre Dame University
Guillermo del Angel
Executive Director, Rare Disease Therapy Area Lead,
Alexion Pharmaceuticals
Igor Dolgalev
Director, Cellular Analytics Laboratory,
NYU Langone Health
Iulian Pruteanu-Malinici
Senior Director Bioinformatics,
Flagship Pioneering/Pioneering Medicines
John Dipersio
Professor,
Washington University in St. Louis
Joyce Lo
Associate Director,
Biogen
Kisha Sivanathan
Senior Scientist,
AstraZeneca
Lee Lichtenstein
Director,
Broad Institute of MIT and Harvard
Leonard Lipovich
adjunct professor,
Kean University
Manoj Kandpal
Director of Research Bioinformatics,
Rockefeller University
Marina Darlow
Incubation Lead, AI Tools for Pharma Research and Reporting,
Takeda Pharmaceutical
Marla Weetall
Sr. Vice President, Pharmacology and Biomarkers,
PTC Therapeutics
Michael Steinbaugh
Director, Data, AI & Genome Sciences,
Merck
Minakshi Guha
Associate Director, LBx Strategy, PSI, Oncology Precision & Translational Medicine,,
Takeda
Preeyam Patel
Director, Translational Sciences,
Spyre Therapeutics
Premi Haynes
Principal Scientist,
Bristol Myers Squibb
Rajib Schubert
Professor,
KAIST
Russell LaMontagne
Chief Executive Officer,
Boston Immune Technologies and Therapeutics, Inc.
Simone Filosto
director,
Kite, A Gilead Company
Stephanie Oestreich
Managing Director,
MMRF
Subhajyoti De
Professor,
Rutgers University
Tara Dutka
Program Director of All of Us Genome Centers,
National Institutes of Health
Thierry Sornasse
Senior Scientific Director,
AbbVie
Vasundhara Pathak
Director, Global Regulatory Affairs / Global Regulatory Lead, Oncology,
CRUK AstraZeneca Antibody Alliance Laboratory
Veena Kochat
Senior Research Scientist,
The University of Texas MD Anderson Cancer Center
Wei-Ju Tseng
Digital Histology,
GSK
Xia Yang
Professor,
UCLA
Yeoun-Jin Kim
Senior Director and Head of Translational Proteomics,
AstraZeneca
Road to PM East_On Dark BG

The Road to Precision Medicine East

Between the events, the conversation carries on online. R&D Spotlights and CEO Thought Leadership sessions run all year, each a stop on the Road to Precision Medicine East.

Precision Medicine East: Frequently Asked Questions

When and where is Precision Medicine East?

March 23–24, 2027, at the Sheraton Boston Hotel in Boston, Massachusetts.

Is Precision Medicine East the same event as NextGen Omics, Spatial & Data US?
Yes. NextGen Omics, Spatial & Data US is now Precision Medicine East, with the same community and depth of content and four interconnected programs.
Who should attend Precision Medicine East?
R&D leaders, clinicians, researchers, data scientists, investors and technology providers working in biomarkers, diagnostics, pathology, multi-omics, and AI and data.
What programs run at Precision Medicine East?
Biomarkers & CDx; Computational Pathology, AI & Precision Diagnostics; Multi-Omics Development & Applications; and AI, Data & Analysis.
Can I meet specific people at Precision Medicine East?
Yes. Nearer the event, you shortlist who you would like to meet, and meetings are arranged before you arrive.

Be part of the conversations shaping
the future of medicine.


, ,

What's been happening at NextGen Omics & Spatial Biology US 2025?

Have a peek into the dynamic panels, engaging roundtables, and hands-on workshops happening in Boston - right now!

spatial biology Track keynote address 
 Spatial Multi-Omics For Target-To-Disease Linkage In Inflammatory Diseases

MARINA BLECK, Principal Scientist, Boehringer Ingelheim

Marina discussed the use of multi omics for faster Faster Target-to- Disease Link (T2DL) with increased confidence and how they can leverage Spatial Biology to enhance the ability to derive insight from human disease tissues.  Finally the Importance of FFPE Tissue Quality for Spatial Biology was discussed with the use of QC scoring to determine which FFPE tissue gives the best spatial transcriptomics results.

spatial biology day one, track 6 
Spatial Biology As A Discovery Pathway

EMRE ARSLAN, Takeda

Emre Arslan from Takeda gave a talk about the use of Spatial Biology as a discovery pathway. First of all providing an update on the current landscape for spatial technologies then analysing how spatial technologies can be used in clinical trial design - such as the ability to identify previously unknown cell types, interactions and microenvironments and providing an ideal foundation for training better AI models. 

day 2 keynote
Single Cell into Spatial and Beyond: Landscape in 2025 and What’s Next?

JASMINE PLUMMER, Director, St Jude Children's Research Hosptial

Jasmine Plummer's day 2 keynote focused on Single cell into spatial and beyond.  "The reason we are in this room is because it’s cutting edge" which is why the single cell and spatial field growing exponentially.

Future directions for the technology include Low throughput, clinical trials, other organisms, more tissue types, epigenomics

Spatial multi-omics, track 4 Keynote
Rapid Single-Cell Spatial Proteomics by Spatial MIST

JUN WANG, Associate Professor, Multiplex Biotechnology Laboratory, Department of Biomedical Engineering, Stony Brook University

"Simpler but more powerful than flow and imaging cytometry"

MIST Technology provides100 times more information than flow cytometry and currently the highest multiplexity is up to 500 markers/ cell.

Single cell track keynote address
Panel Application Of Single Cell Omics In Clinical Monitoring

PRIYA CHOCKALINGAM, Vice President, Head of Clinical BioAnalytics & Translational Sciences, Beam Therapeutics

Priya's talk focused on Genome Editing Technologies for Gene & Cell Therapy and how cell & gene therapies require a specialized regulatory approach compared to other modalities. Appropriate assessments should therefore be put in place in both nonclinical and clinical stages to address safety concerns.

Various methods to assess off-target editing effects have evolved in the last decade. However, limitations remain in balancing accuracy vs sensitivity of these new techniques.

The direct assessment of off-target effects in vivo and in patients is particularly challenging.

Novel single-cell technologies enable quantitation/co-occurrence of on-/off-target editing through patient time-course of treatment

single cell  
Comparative Insights In Single Cell RNA-seq & Advances In Large-Scale Multimodal Profiling

ZORA MODRUSAN, Senior Director NGS, Genentech

Zora focused on both key insights and future directions of single cell RNA-Seq.  scRNA-seq technologies were evaluated and the differences in performance across various metrics such as sensitivity, throughput and cost were compared across different systems.

The Overloading And unpacKing (OAK) method provides a reliable solution for large-scale molecular profiling that incorporates multiple data modalities.

Moving forward they will continue to evaluate the latest scRNA-seq kits to understand differences and guide optimal performance. Zora would also like to enhance OAK's capabilities by integrating additional modalities and applying the platform to a wide range of biological systems.

Key Event Highlights

An unmissable journey awaits you: from celebrated keynote speakers and insightful private roundtables, to the Young Scientist Awards. Discover the moments that will transform your NextGen Omics, Spatial & Data US experience. 

2026 Featured Speakers

Dr. Elaine Joseph
Director, Precision Medicine,
AstraZeneca
Enrico Mossotto
Senior Director,
MeiraGTx
Giorgio Gaglia
Senior Principal Scientist,
Sanofi
Jing He
Associate Director,
Novo Nordisk
Zora Modrusan
Senior Director of Genomics,
Genentech
Aarno Palotie
Research Director of the Human Genomics Program,
The University of Helsinki, Institute for Molecular Medicine Finland FIMM
Aaron Berlin
Chief Technology Officer,
Singular Genomics
Abeer Obaid
Senior Scientist,
Abbvie
Aditi Singh
Director of Bioinformatics,
Wayne State University
Ahmet Coskun
Professor of Biomedical Engineering,
Georgia Institute of Technology
Alex Tamburino
Director, Spatial & Single Cell Multiomics,
Merck & Co
Ali Ebrahimi
Associate Director,
Takeda
Alina Ainbinder
Principal Scientist,
Takeda
Amanda Dy
Reseacher,
Toronto Metropolitan University
Amit Mitra
Associate Professor,
Auburn University
Andrew Owens
Application Scientist,
Mission Bio
Anita Bansal
Associate Director, Lead Translational Bioinformatics,
UCB Pharma
Arutha Kulasinghe
Associate Professor,
The University of Queensland
Ashot Harutyunyan
Academic Associate,
McGill University
Aziz Al'Khafaji
Director, Molecular R&D - Genomics Platform,
Broad Institute of MIT and Harvard
Banishree Saha
Associate Director, Global Biomarker and Assay Analytical Lead,
Takeda Pharmaceuticals
Bharat Thyagarajan
Associate Professor,
University of Minnesota
Carina Emery
Lead Product Manager,
Miltenyi Biotec
Carol Hu
Senior Scientist,
Merck Research Laboratories
Chandra Saravanan
Pathologist,
Novartis Pharma
Chanyoung Park
Research Scientist,
Stellaromics
Colles Price
Co-Founder & Chief Executive Officer,
TALOX
Daniel Carney
Sales Director,
Fovus
Daniel Jones
Staff Scientist,
Fred Hutchinson Cancer Research Center
David Gallegos
Senior Scientist,
Takeda
Di He
Senior Scientist,
Merck
Dr. Deepak Veeregowda
Chief Executive Officer,
QT Sense
Dulguun Amgalan
Staff Scientist,
Illumina AI Lab
Emre Arslan
Associate Director,
Takeda
Eugenia Lyashenko
Senior Principal Scientist, Lab Head,
Sanofi
Fei Chen
Principal Investigator & Assistant Professor,
Broad Institute
Fei Zou
Professor,
University of North Carolina
Fengbo Ren
Founder and CEO,
Fovus
Gabor Balazsi
Henry Laufer Professor,
Stony Brook University
Gervaise Henry
Vice President, Solutions Engineering,
Manifold AI
Gloria Pryhuber
Professor, Department of Pediatrics, Neonatology (SMD),
URMC
Greg Warner
Senior Field Applications Scientist,
Cell Signaling Technology
Gregory Mendez
Principal Scientist,
Sanofi
Gulpreet Kaur
Chief Businesss Officer,
Elucidate Bio
Hagai Marmor-Kollet
Investment Associate,
aMoon Fund
Hansueli Meyer
Senior Director, Site Leader and Head of Systems Integration Spatial Technologies,
Miltenyi Biotec
Heather Knight
Senior Scientist I,
Abbvie
Hua Li
Director of Computational Biology,
Stowers Institute for Medical Research
Ioannis Ragoussis
Professor,
McGill University
Irene Ghobrial
Professor of Medicine, Senior Vice President of Experimental Therapy, Lavine Family Chair for Preventative Cancer Therapy,
Dana-Farber Cancer Institute
Isabella Polic
Graduate Student,
The University of Texas MD Anderson Cancer Center
Iulian Pruteanu-Malinici
Senior Director Bioinformatics,
Flagship Pioneering/Pioneering Medicines
Ivan Lebedev
President,
Verdant Center for Spatial Biology
Jackson Brougher
Assistant Professor & Space Health Research Scientist,
Translational Research Institute For Space Health
Jan Schejbal
Senior Scientist II,
AbbVie
Jeff Byland
Senior Science & Technology Advisor,
10x Genomics
Jeff June
Chief Executive Officer,
Ischemia Care
Jennifer Frahm
Director, Field Application Scientist,
Standard BioTools Inc.
Jia-Ren Lin
Technical Director of Tissue Imaging,
Harvard Medical School
Jiang He
Vice President, R&D, Reagents,
Vizgen
Jiwoon Park
Founder of the Spatial Atlas of Human Anatomy,
Weill Cornell Medicine
Joann Arce
Assistant Professor,
Boston Children's Hospital, Harvard Medical School
Jochen Lennerz
Chair,
EFLM Task Group on Integrated Diagnostics
Joseph Beechem
CSO & Sr. VP of Research & Development,
Bruker Spatial Biology
Kisha Sivanathan
Senior Scientist,
AstraZeneca
Leonard Lipovich
adjunct professor,
Kean University
Madhumala Sadanandappa
Scientist,
Dartmouth Health
Mahmud Hossain
Senior Scientist II,
Sanofi
Manisha Brahmachary
Associate Director,
Sanofi USA
Manoj Kandpal
Director of Research Bioinformatics,
Rockefeller University
Maria Forero
Senior Advisor,
Accelmed
Nicolas Fernandez
Senior Computational Scientist,
Broad Institute of MIT and Harvard
Nir Ben Chetrit
Assistant Professor,
Weill Cornell Medicine
Pei Chen
Principal Scientist,
BMS
Qingqing Wang
Associate Director,
Regeneron
Rea Dabelic
Sr Staff Product Manager,
Illumina
Sahil Seth
Principal Scientist,
Bristol Myers Squibb
Samouil Farhi
Director, Spatial Technology Platform,
Broad Institute
Samuel Harrison
Technology and Application Science,
Miltenyi Biotec
Sara Hamon
Executive Director, Precision Medicine,
Regeneron Pharmaceuticals
Saum Ghodoussipour
Associate Professor,
Rutgers University
Shanye Yin
Assistant Professor,
Albert Einstein College of Medicine
Sharvari Gujja
Data Scientist, Abbvie,
Abbvie Inc.
Shoh Asano
Senior Principal Scientist,
Pfizer
Silvia Siso
Pathologist,
Abbvie
Simona Cristea
Head of Genomics and AI,
Dana-Farber Cancer Institute
Sindi Nexhipi
PostDoc,
DKFZ
Sophia George
Professor,
University of Miami
Soumya Negi
Senior Advisor,
Eli Lilly
Sourav Choudhury
Group Head, Distinguished Scientist,
Sanofi
Stephen Baylin
Head of the Cancer Genetics and Epigenetics Program,
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Steven Barthel
Assistant Professor of Dermatology,
Harvard Medical Scool, Mass General Brigham
Suhas Vasaikar
Associate Director,
Pfizer Ltd
Sunhwa Kim
Associate Scientific Director,
AbbVie
Terry Melim
Sr Research Analyst,
Abbvie
Tes Mersha
Professor,
Indiana University School of Medicine
Tad Geroge
Sr VP Biology R&D,
RareCyte Inc
Tibby Duan
Senior STOmics Product Manager,
Complete Genomics
Tim Harris
Venture Partner,
SV Health Investors
Unsubscribe me
Chief Executive Officer,
AmberGen
Uttiya Basu
Professor,
Columbia University
Vinay Mohta
Chief Executive Officer & Co-Founder,
Manifold AI
Virginia Savova
Board director,
Scailyte
Vitalay Fomin
CEO,
Numenos
William Henley
Co-Founder and VP of Research & Innovation,
Codetta Bio
Xian Wang
Research Project Manager,
University of Pittsburgh
Xuyu Qian
Assistant Professor, Department of Pediatrics, Division of Neurology,
Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania
Yea Jin Kaeser-Woo
Senior Director,
Eli Lilly and Company
Yufei Huang
Professor,
University of Pittsburgh
Zongmei Gao
senior scientist ii,
abbvie

Interested in Sponsoring NextGen Omics & Spatial Biology US 2025?

Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics & Spatial Biology US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.